<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05126615</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A01108-47</org_study_id>
    <nct_id>NCT05126615</nct_id>
  </id_info>
  <brief_title>Contribution of Auriculotherapy in the Management of Mastectomy With Immediate Reconstruction by Latissimus Dorsi Flap (ATMAGD)</brief_title>
  <acronym>ATMAGD</acronym>
  <official_title>Contribution of Auriculotherapy in the Management of Mastectomy With Immediate Reconstruction by Latissimus Dorsi Flap (ATMAGD)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramsay Générale de Santé</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ramsay Générale de Santé</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Over the past decade, more and more healthcare professionals are using auriculotherapy as a&#xD;
      preventative and effective therapy for pain. This therapy is applied by odontologists,&#xD;
      anesthetists, surgeons, etc., to alleviate chronic pain. The effects of auriculotherapy are&#xD;
      known in particular in reducing preoperative anxiety, pain in cancer patients and&#xD;
      postoperative pain.&#xD;
&#xD;
      The aim of this study is to assess the effectiveness of adding auriculotherapy to the&#xD;
      standard global anesthetic protocol, compared to this single reference protocol, on the&#xD;
      incidence at 3 months post-intervention of Chronic Post-Surgical Pain, in patients operated&#xD;
      for a mastectomy with reconstruction immediate by latissimus dorsi flap.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    difficulty of recruitment&#xD;
  </why_stopped>
  <start_date type="Actual">May 10, 2019</start_date>
  <completion_date type="Actual">September 17, 2021</completion_date>
  <primary_completion_date type="Actual">August 6, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence, or not, of Chronic Post-Surgical Pain (DCPC)</measure>
    <time_frame>3 months</time_frame>
    <description>DCPC noted during the clinical examination of the 3rd postoperative month :&#xD;
- score obtained at BPI : Brief Pain Inventory (9 items : many items with answers between 0 and 10)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Presence, or not, of Chronic Post-Surgical Pain (DCPC)</measure>
    <time_frame>3 months</time_frame>
    <description>DCPC noted during the clinical examination of the 3rd postoperative month :&#xD;
- score obtained at DN4 (neuropathic pain) : 4 different items</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Mastectomy</condition>
  <condition>Auriculotherapy</condition>
  <arm_group>
    <arm_group_label>Patients with auriculotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mastectomy operated patient then, auriculotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient with placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Mastectomy operated patient then, they received placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Auriculotherapy</intervention_name>
    <description>Application of a bolus of 5 μ of liquid nitrogen via a cryospray on the auriculotherapy points A4, C18, D9, C9, DIX, H13, G14 and FXVII, chosen according to a neurophysiological reasoning taking into account the surgical intervention performed and innervation of the anatomical region affected by the intervention.</description>
    <arm_group_label>Patients with auriculotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Chronic Post-Surgical Pain evaluation</intervention_name>
    <description>Different questionnaires :&#xD;
BPI : Brief Pain Inventory DN4</description>
    <arm_group_label>Patient with placebo</arm_group_label>
    <arm_group_label>Patients with auriculotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women patient over 18 years-old&#xD;
&#xD;
          -  Patient scheduled for a mastectomy with immediate reconstruction by latissimus dorsi&#xD;
             flap with or without symmetrization on the contralateral breast.&#xD;
&#xD;
          -  Patient affiliated or beneficiary of a social security scheme.&#xD;
&#xD;
          -  Patient who has given her free and informed consent.&#xD;
&#xD;
          -  Preoperative blood test showing no contraindication to the operation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal of the patient.&#xD;
&#xD;
          -  No indication for auriculotherapy:&#xD;
&#xD;
          -  Patient having a heavy treatment with neuroleptics,&#xD;
&#xD;
          -  Or tricyclic antidepressants which interfere with the action of auriculotherapy.&#xD;
&#xD;
          -  Patient undergoing long-term morphine treatment for chronic pain.&#xD;
&#xD;
          -  Patient with unweaned opioid addiction.&#xD;
&#xD;
          -  Chronic painful patient.&#xD;
&#xD;
          -  Protected patient: Major under guardianship, curatorship or other legal protection,&#xD;
             deprived of liberty by judicial or administrative decision; Hospitalized without&#xD;
             consent.&#xD;
&#xD;
          -  Pregnant, breastfeeding or parturient woman.&#xD;
&#xD;
          -  Patient participating in another interventional study.&#xD;
&#xD;
          -  Patient who had already participated in this study as part of first breast surgery.&#xD;
&#xD;
          -  Patient receiving regular care by auriculotherapy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital Privé Paul d'Egine</name>
      <address>
        <city>Champigny-sur-Marne</city>
        <zip>94500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 9, 2021</study_first_submitted>
  <study_first_submitted_qc>November 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2021</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

